These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14592494)

  • 21. Potent, non-thiol inhibitors of farnesyltransferase.
    Breslin MJ; deSolms SJ; Giuliani EA; Stokker GE; Graham SL; Pompliano DL; Mosser SD; Hamilton KA; Hutchinson JH
    Bioorg Med Chem Lett; 1998 Dec; 8(23):3311-6. PubMed ID: 9873725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.
    Brunner TB; Hahn SM; Gupta AK; Muschel RJ; McKenna WG; Bernhard EJ
    Cancer Res; 2003 Sep; 63(18):5656-68. PubMed ID: 14522880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitors.
    Le Diguarher T; Ortuno JC; Dorey G; Shanks D; Guilbaud N; Pierré A; Fauchère JL; Hickman JA; Tucker GC; Casara PJ
    Bioorg Med Chem; 2003 Jul; 11(14):3193-204. PubMed ID: 12818682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability.
    Tong Y; Lin NH; Wang L; Hasvold L; Wang W; Leonard N; Li T; Li Q; Cohen J; Gu WZ; Zhang H; Stoll V; Bauch J; Marsh K; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2003 May; 13(9):1571-4. PubMed ID: 12699757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitors of protein farnesyltransferase as novel anticancer agents.
    Ohkanda J; Knowles DB; Blaskovich MA; Sebti SM; Hamilton AD
    Curr Top Med Chem; 2002 Mar; 2(3):303-23. PubMed ID: 11944822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orally bioavailable farnesyltransferase inhibitors as anticancer agents in transgenic and xenograft models.
    Liu M; Bishop WR; Nielsen LL; Bryant MS; Kirschmeier P
    Methods Enzymol; 2001; 333():306-18. PubMed ID: 11400347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and early structure-activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate.
    Schlitzer M; Böhm M; Sattler I; Dahse HM
    Bioorg Med Chem; 2000 Aug; 8(8):1991-2006. PubMed ID: 11003144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of new phenothiazine derivatives bearing a pyrazole unit as protein farnesyltransferase inhibitors.
    Baciu-Atudosie L; Ghinet A; Farce A; Dubois J; Belei D; Bîcu E
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6896-902. PubMed ID: 23036952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of farnesyltransferase and geranylgeranyltransferase-I for antitumor therapy: substrate-based design, conformational constraint and biological activity.
    Dinsmore CJ; Bell IM
    Curr Top Med Chem; 2003; 3(10):1075-93. PubMed ID: 12769709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency.
    Bell IM; Gallicchio SN; Abrams M; Beese LS; Beshore DC; Bhimnathwala H; Bogusky MJ; Buser CA; Culberson JC; Davide J; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hamilton KA; Hartman GD; Heimbrook DC; Homnick CF; Huber HE; Huff JR; Kassahun K; Koblan KS; Kohl NE; Lobell RB; Lynch JJ; Robinson R; Rodrigues AD; Taylor JS; Walsh ES; Williams TM; Zartman CB
    J Med Chem; 2002 Jun; 45(12):2388-409. PubMed ID: 12036349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different amino acid replacements in CAAX-tetrapeptide based peptidomimetic farnesyltransferase inhibitors.
    Schlitzer M; Sattler I; Dahse HM
    Arch Pharm (Weinheim); 1999 Apr; 332(4):124-32. PubMed ID: 10327885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors.
    Ding CZ; Hunt JT; Ricca C; Manne V
    Bioorg Med Chem Lett; 2000 Feb; 10(3):273-5. PubMed ID: 10698452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
    Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors.
    Le Diguarher T; Ortuno JC; Shanks D; Guilbaud N; Pierré A; Raimbaud E; Fauchère JL; Hickman JA; Tucker GC; Casara PJ
    Bioorg Med Chem Lett; 2004 Feb; 14(3):767-71. PubMed ID: 14741286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors.
    Schlitzer M
    Curr Pharm Des; 2002; 8(19):1713-22. PubMed ID: 12171543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 4-(acylaminomethyl)benzamides and their evaluation as potential anticancer agents.
    Schlitzer M; Sattler I; Friese A; Zündorf I; Dingermann T
    Anticancer Res; 2000; 20(3A):1723-6. PubMed ID: 10928099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferase.
    Dinsmore CJ; Bogusky MJ; Culberson JC; Bergman JM; Homnick CF; Zartman CB; Mosser SD; Schaber MD; Robinson RG; Koblan KS; Huber HE; Graham SL; Hartman GD; Huff JR; Williams TM
    J Am Chem Soc; 2001 Mar; 123(9):2107-8. PubMed ID: 11456854
    [No Abstract]   [Full Text] [Related]  

  • 38. The farnesyltransferase inhibitor L-744,832 inhibits the growth of astrocytomas through a combination of antiproliferative, antiangiogenic, and proapoptotic activities.
    Feldkamp MM; Lau N; Guha A
    Ann N Y Acad Sci; 1999; 886():257-60. PubMed ID: 10667233
    [No Abstract]   [Full Text] [Related]  

  • 39. Farnesyltransferase inhibitors.
    Adjei AA
    Cancer Chemother Biol Response Modif; 2005; 22():123-33. PubMed ID: 16110610
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis, molecular modeling, and structure-activity relationship of benzophenone-based CAAX-peptidomimetic farnesyltransferase inhibitors.
    Sakowski J; Böhm M; Sattler I; Dahse HM; Schlitzer M
    J Med Chem; 2001 Aug; 44(18):2886-99. PubMed ID: 11520197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.